Solvotrin Therapeutics Competitors and Similar CompaniesClear all

Biogen's competitors and similar companies include Cipla.
Biogen
Biogen
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
Cipla
Cipla
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.
Founding Date
Founding Date
1978
Founding Date
1935
Type
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Locations
Mumbai, IN HQ
South Melbourne, AU
Mumbai, IN
Nairobi, KE
Cape Town, ZA
Durban, ZA
Durban, ZA
see more
Employees
Employees
7,57013% decrease
Employees
27,7644% increase

Financial

Revenue (est.)
Revenue (est.)
$9.8b (FY, 2023)
Revenue (est.)
₹254.5b (FY, 2024)
Cost of goods
Cost of goods
$2.5b (FY, 2023)
Cost of goods
₹88.2b (FY, 2024)
Gross profit
Gross profit
$7.3b (FY, 2023)
Gross profit
₹169.5b (FY, 2024)
Net income
Net income
$1.2b (FY, 2023)
Net income
₹41.6b (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Cipla
HQ
Mumbai, IN
Employees
27,764↑ 4% increase

Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.

View company